# Francesco Locatelli

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/francesco-locatelli/

## Facts

| Field | Value |
| --- | --- |
| Citations | 44,874 |
| Field | Dialysis and Renal Disease Management |
| h-index | 99 |
| i10-index | 413 |
| Last Known Institution | University of Modena and Reggio Emilia |
| OpenAlex ID | https://openalex.org/A5071768099 |
| ORCID iD | https://orcid.org/0009-0001-1630-7950 |
| Works | 877 |

## Researcher papers

Showing 12 of 17.

- [Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients](https://scholariq.org/papers/targeting-hypoxia-inducible-factors-for-the-treatment-of-anemia-in-chronic/)
- [K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease](https://scholariq.org/papers/k-doqi-clinical-practice-guidelines-for-bone-metabolism-and-disease-in-chronic/)
- [Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia](https://scholariq.org/papers/normalization-of-hemoglobin-level-in-patients-with-chronic-kidney-disease-and/)
- [Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency](https://scholariq.org/papers/effect-of-the-angiotensin-converting-enzyme-inhibitor-benazepril-on-the/)
- [Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS)](https://scholariq.org/papers/health-related-quality-of-life-as-a-predictor-of-mortality-and-hospitalization/)
- [Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/iron-management-in-chronic-kidney-disease-conclusions-from-a-kidney-disease/)
- [Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement](https://scholariq.org/papers/kidney-disease-improving-global-outcomes-guidelines-on-anaemia-management-in/)
- [Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)](https://scholariq.org/papers/anaemia-in-haemodialysis-patients-of-five-european-countries-association-with/)
- [Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial](https://scholariq.org/papers/targeted-release-budesonide-versus-placebo-in-patients-with-iga-nephropathy/)
- [Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials](https://scholariq.org/papers/change-in-albuminuria-as-a-surrogate-endpoint-for-progression-of-kidney-disease/)
- [Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management](https://scholariq.org/papers/hypersensitivity-reactions-to-intravenous-iron-guidance-for-risk-minimization/)
- [The MEST score provides earlier risk prediction in lgA nephropathy](https://scholariq.org/papers/the-mest-score-provides-earlier-risk-prediction-in-lga-nephropathy/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)

## Researcher university

- [University of Modena and Reggio Emilia](https://scholariq.org/institutions/university-of-modena-and-reggio-emilia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.